Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 Vaccines Cost-Effectiveness Analysis: A Scenario for Iran Publisher



Vaezi A1 ; Meysamie A2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, 8174673461, Iran
  2. 2. Department of Community Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, 1416753955, Iran
  3. 3. Community Based Participatory Research Center, Iranian Institute for Reduction of High Risk Behaviors, Tehran University of Medical Sciences, Tehran, 1416753955, Iran

Source: Vaccines Published:2022


Abstract

COVID-19 vaccines are supposed to be critical measure for ending the pandemic. Govern-ments had to decide on the type of vaccine to provide for their population. In this decision-making process, cost-effectiveness analysis is considered a helpful tool. This study is a cost-effectiveness analysis utilized to calculate the incremental cost per averted disability-adjusted life year (DALY) by vaccination compared to no vaccination for different COVID-19 vaccines. The incremental cost-effectiveness ratio (ICER) for a vaccination with COVID-19 vaccines was estimated at 6.2 to 121.2 USD to avert one DALY and 566.8 to 10,957.7 USD per one death. The lowest and highest ICERs belong to Ad26.COV2.S and CoronaVac, respectively. Considering the scenario of Iran, vaccines that are recommended include ad26.cov2.s, chadox1-S, rAd26-S + rAd5-S, and BNT162b2 in the order of recommendation. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Related Docs
View other Related Docs
1. Recent Developments in Sars-Cov-2 Vaccines: A Systematic Review of the Current Studies, Reviews in Medical Virology (2023)
2. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
3. The Effectiveness of Covid-19 Vaccines in Reducing the Incidence, Hospitalization, and Mortality From Covid-19: A Systematic Review and Meta-Analysis, Frontiers in Public Health (2022)
4. Covid-19 Vaccinations: The Unknowns, Challenges, and Hopes, Journal of Medical Virology (2022)
5. Vlp-Based Covid-19 Vaccines: An Adaptable Technology Against the Threat of New Variants, Vaccines (2021)
6. Molecular Variants of Sars-Cov-2: Antigenic Properties and Current Vaccine Efficacy, Medical Microbiology and Immunology (2022)
7. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
8. Acute Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia Post Covid-19 Vaccination; a Systematic Review, Journal of the Neurological Sciences (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (10)
Mohammadreza Salehi (3)
Other Related Docs
9. Effectiveness of Covid-19 Vaccines Against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies, Vaccines (2022)
10. Covid-19 Vaccines Mix-And-Match: The Concept, the Efficacy and the Doubts, Journal of Medical Virology (2022)
11. Safety and Immunogenicity of an Inactivated Virus Particle Vaccine for Sars-Cov-2, Biv1-Coviran: Findings From Double-Blind, Randomised, Placebo-Controlled, Phase I and Ii Clinical Trials Among Healthy Adults, BMJ Open (2022)
12. Covid-19 Vaccine Boosters: The Good, the Bad, and the Ugly, Vaccines (2021)
13. Efficacy and Safety of an Inactivated Virus-Particle Vaccine for Sars-Cov-2, Biv1-Coviran: Randomised, Placebo Controlled, Double Blind, Multicentre, Phase 3 Clinical Trial, BMJ (2023)
14. Covid-19 Infection Risk Following Elective Arthroplasty and Surgical Complications in Covid-19-Vaccinated Patients: A Multicenter Comparative Cohort Study, Arthroplasty Today (2022)
15. Association of Sars-Cov-2 Vaccination or Infection With Bell Palsy: A Systematic Review and Meta-Analysis, JAMA Otolaryngology - Head and Neck Surgery (2023)
16. A Comparison Between Sars-Cov-1 and Sars-Cov2: An Update on Current Covid-19 Vaccines, DARU# Journal of Pharmaceutical Sciences (2022)
17. Diagnostic Performance of a Novel Antigen-Capture Elisa for the Detection of Sars-Cov-2, Analytical Biochemistry (2023)
18. Appraisal of Sars-Cov-2 Mutations and Their Impact on Vaccination Efficacy: An Overview, Journal of Diabetes and Metabolic Disorders (2022)
19. Short-Term Safety of Covaxin, Sinopharm, Sputnik V, and Astrazeneca Covid-19 Vaccines Among Iranian Healthcare Workers: A Cross-Sectional Study, Archives of Clinical Infectious Diseases (2024)
20. A Systematic Review and Meta-Analysis of Immune Response Against First and Second Doses of Sars-Cov-2 Vaccines in Adult Patients With Hematological Malignancies, International Immunopharmacology (2022)
21. Covid-19 Vaccination Challenges: A Mini-Review, Human Vaccines and Immunotherapeutics (2022)
22. Sars-Cov-2 Antibody Response After Bbibp-Corv (Sinopharm) Vaccination in Cancer Patients: A Case-Control Study, Frontiers in Medicine (2023)
23. The Quest for a Better Fight: How Can Nanomaterials Address the Current Therapeutic and Diagnostic Obstacles in the Fight Against Covid-19?, Journal of Drug Delivery Science and Technology (2022)
24. Importance of the Covid-19 Vaccine Booster Dose in Protection and Immunity, Vaccines (2022)
25. Delving Into Revolutionary Sars-Cov-2 Vaccine Approaches: Molecular and Virological Examinations; Principles of Sars-Cov-2 Vaccine Platform; [Adentrandose En Enfoques Revolucionarios De Vacunas Sars-Cov-2: Examenes Moleculares Y Virologicos; Principios De La Plataforma De Vacunas Sars-Cov-2], Vacunas (2024)
26. Safety and Immunogenicity of a Recombinant Receptor-Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine™) Against Covid-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial, Journal of Medical Virology (2023)
27. Cutaneous Adverse Reactions Following Covid-19 Vaccinations: A Systematic Review and Meta-Analysis, Journal of Cosmetic Dermatology (2022)
28. Immunologic Response, Efficacy, and Safety of Vaccines Against Covid-19 Infection in Healthy and Immunosuppressed Children and Adolescents Aged 2 – 21 Years Old: A Systematic Review and Meta-Analysis, Journal of Clinical Virology (2022)
29. Vaccines for Covid-19: A Systematic Review of Feasibility and Effectiveness, Infectious Disorders - Drug Targets (2022)
30. Short-Term Side Effects of Covid-19 Vaccines Among Healthcare Workers: A Multicenter Study in Iran, Scientific Reports (2024)
31. The Clinical Impact of Mrna Therapeutics in the Treatment of Cancers, Infections, Genetic Disorders, and Autoimmune Diseases, Heliyon (2024)
32. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
33. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)
34. Short-Term Sars-Cov-2 Re-Infection Rate in Vaccinated Health Workers Based on Received Vaccines: A Cross-Sectional Study, Current Respiratory Medicine Reviews (2023)
35. Association of New-Onset Seizures With Sars-Cov-2 Vaccines a Systematic Review and Meta-Analysis of Randomized Clinical Trials, JAMA Neurology (2024)
36. Characterization of Stability, Safety and Immunogenicity of the Mrna Lipid Nanoparticle Vaccine Iribovax® Against Covid-19 in Nonhuman Primates, Journal of Controlled Release (2023)
37. Side Effects and Short-Term Safety of Covid-19 Vaccines for Pregnant Women: A Case Study of Southeast Iran, Archives of Clinical Infectious Diseases (2023)
38. Aging & Covid-19 Susceptibility, Disease Severity, and Clinical Outcomes: The Role of Entangled Risk Factors, Experimental Gerontology (2021)
39. T Helper Type (Th1/Th2) Responses to Sars-Cov-2 and Influenza a (H1n1) Virus: From Cytokines Produced to Immune Responses, Transplant Immunology (2022)
40. Seroconversion Following the First, Second, and Third Dose of Sars-Cov-2 Vaccines in Immunocompromised Population: A Systematic Review and Meta-Analysis, Virology Journal (2022)
41. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
42. Covid-19 Transmission, Vulnerability, Persistence and Nanotherapy: A Review, Environmental Chemistry Letters (2021)
43. Comparison of Astrazeneca and Sinopharm Vaccines As Boosters in Protection Against Covid-19 Infection, Biologicals (2023)
44. The Effect of Covid-19 Mrna Vaccines Against Postvaccination Laboratory-Confirmed Sars-Cov-2 Infection, Symptomatic Covid-19 Infection, Hospitalization, and Mortality Rate: A Systematic Review and Meta-Analysis, Expert Review of Vaccines (2022)
45. Safety and Efficacy of Rcp Recombinant Spike Protein Covid-19 Vaccine Compared to Sinopharm Bbibp: A Phase Iii, Non-Inferiority Trial, Heliyon (2024)
46. Immunogenicity of Covid-19 Mrna Vaccines in Immunocompromised Patients: A Systematic Review and Meta-Analysis, European Journal of Medical Research (2022)
47. Sudden Sensorineural Hearing Loss After Receiving an Inactivated Viral Vaccine, Sinopharm: Two-Case Report, SAGE Open Medical Case Reports (2023)
48. Dissection of Non-Pharmaceutical Interventions Implemented by Iran, South Korea, and Turkey in the Fight Against Covid-19 Pandemic, Journal of Diabetes and Metabolic Disorders (2021)
49. Structural Evolution of Delta Lineage of Sars-Cov-2, International Journal of Biological Macromolecules (2023)
50. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)